user

New Swedish Clinical Study Published In The British Journal Of Dermatology Demonstrates Superiority Of AI-Algorithm Guided Melanoma Diagnosis

Dermalyser AI-driven support tool achieved remarkable sensitivity and specificity values of 95% and 85%, respectively, with these figures increasing to...

Alzheimer’s Research & Therapy: Linus Health Digital Clock and Recall Test Detects Early Cognitive Impairment in Over 80% of Patients Who Were Misclassified in Commonly Used Paper-Based Test

Study published in peer-reviewed journal demonstrates superior sensitivity and accuracy of Linus Health’s digital cognitive assessment over the Mini-Mental State...

MHRA Grants ADvantage Therapeutics Innovative Licensing and Access Pathway (ILAP) Designation for Novel Lead Product AD04™ for Phase 2b Trial in Alzheimer’s Disease

ILAP Designation accelerates patient access and commercialization  MIAMI, APRIL 5, 2023 (GLOBE NEWSWIRE) – ADvantage Therapeutics, Inc. (“ADvantage” or “the...

error: Content is protected !!